Be careful! The nine batches of drugs are unqualified and have been seized by the regulatory authorities

Recently, Heilongjiang Provincial Drug Administration announced that 9 batches of drugs such as madder (Yinpian) produced by Harbin Qigongtang traditional Chinese medicine Yinpian Co., Ltd were unqualified For the unqualified drugs, the drug supervision and Administration Department of the place where the source of the tested products is located has taken control measures such as sealing and detaining, and asked the sampled unit to stop selling and using the batch of products Be careful! These 9 batches of drugs are unqualified The regulatory authorities have seized and seized the unqualified drugs, including troxerutin tablets with batch number of 20170202 produced by Shanghai Huangxiang Tieli Lantian Pharmaceutical Co., Ltd.; asarone for injection produced by Hunan wuzhoutong Pharmaceutical Co., Ltd.; Yuanzhi (decoction pieces) with batch number of 170529 produced by Bozhou Yonggang Decoction Pieces Factory Co., Ltd; The vinegar myrrh with batch number of 180401 produced by Bozhou Zhangzhongjing Herbal Pieces Co., Ltd.; the papaya with batch number of 161201 and the radish with batch number of 161001 produced by Anhui people's Herbal Pieces Co., Ltd.; the jujube kernel with batch number of 20171101 produced by Anhui hejitang Herbal Pieces Co., Ltd (stir fried); Anhui Guanghe traditional Chinese Medicine Co., Ltd produces 171123 oysters and Harbin Qigongtang traditional Chinese medicine decoction pieces Co., Ltd produces 160701 Rubia (decoction pieces) Be careful! The nine batches of drugs are unqualified and have been seized by the regulatory authorities At present, the substandard drugs (Chinese herbal pieces) produced by enterprises outside the province have been reported to the relevant provincial (municipal) regulatory authorities for treatment, and the municipal (local) drug regulatory authorities where the source unit is located are required to produce, sell and use the substandard drugs (Chinese herbal pieces) in accordance with the provisions of Article 73, 714 and 75 of the drug administration law of the people's Republic of China To investigate and deal with the illegal acts, and to publicize the treatment results of the enterprises or units involved in the production, sale and use of unqualified drugs (herbal pieces) within three months, and to report the relevant information to the provincial drug administration in a timely manner Details of substandard drugs